CNSP Latest Press Releases

-- June 8, 2026 --

CNS Pharmaceuticals CFO, Steve O'Loughlin, Highlights Company's Recent $22.5M Financing in Virtual Investor "What This Means" Segment ACCESS Newswire 9:15 AM

-- May 20, 2026 --

CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress ACCESS Newswire 9:02 AM

-- May 14, 2026 --

CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress ACCESS Newswire 8:05 AM

-- May 4, 2026 --

CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing ACCESS Newswire 7:00 AM

-- March 11, 2026 --

CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline ACCESS Newswire 8:35 AM

-- March 2, 2026 --

CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team ACCESS Newswire 8:25 AM

-- February 17, 2026 --

CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation ACCESS Newswire 8:25 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software